Literature DB >> 2445649

Use of molecular probes in the study of endocrine diseases.

R V Lloyd1.   

Abstract

DNA hybridization techniques are now commonly used in studies of endocrine disease. Although solution and filter hybridization have been more widely used in endocrine studies, ISH offers many advantages to the pathologist. Individual cells can be visualized directly with the microscope to study the expression of specific gene products. ISH is somewhat similar to immunohistochemistry and can be set up rapidly in most histology laboratories, especially when nonradioactive biotinylated probes are used. The ability to combine ISH with immunochemical techniques offers to the pathologist the use of two powerful diagnostic tools simultaneously. Although DNA hybridization has only begun to have an impact in diagnostic pathology, many studies using this technique in the diagnosis of endocrine diseases are emerging. The availability of more probes, especially with nonradioactive detection systems, should accelerate the application of these techniques in diagnostic pathology. As the number of molecular probes available for hybridization studies increases, pathologists can have a major impact in this field by carefully evaluating probes that have potential diagnostic value for their specificity and sensitivity in a wide variety of normal and abnormal human tissues. Such careful and critical analyses will contribute greatly to the confidence with which these molecular probes can be used as another tool in the analysis of difficult diagnostic lesions. Molecular hybridization techniques will also contribute greatly to our knowledge of basic biology and pathophysiology in the study of abnormal gene expression in endocrine and other pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445649     DOI: 10.1016/s0046-8177(87)80402-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

Review 1.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

3.  Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.

Authors:  H Uhlig; W Saeger; S Fehr; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Heterogeneity in expression of S100 beta mRNA in human melanoma and pleomorphic adenoma demonstrated by in situ hybridization.

Authors:  C F Landry; H J Kahn; R Baumal; A Marks; I R Brown
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

6.  Overview of Neuroendocrine Cells and Tumors.

Authors:  Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

7.  Comparison of in situ hybridization and immunocytochemistry for the detection of residual beta cells in the pancreas of streptozotocin-treated diabetic rats.

Authors:  J Van Gompel; T Mahler; M De Paepe; G Klöppel
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.